BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2010
View Archived Issues
Novel mixed-format HIV vaccine shows promise in phase I trial in healthy adult volunteers
Read More
Antares and Population Council report phase II trial results for transdermal contraceptive gel
Read More
Savient presents update on BLA resubmission for Krystexxa for chronic gout
Read More
Novartis launches Fanapt in the U.S. for schizophrenia
Read More
PhotoMedex and Galderma Laboratories sign copromotion agreement for Metvixia for AK
Read More
Ablynx generates Nanobodies against an ion channel and CXCR4 receptor
Read More
Amarin initiates enrollment into MARINE and ANCHOR phase III trials of AMR-101
Read More
BioMarin initiates phase I clinical trial of SMT-C1100 for Duchenne muscular dystrophy
Read More
Inhibitex presents update on development of SA3Ag vaccine, FV-100 and INX-189
Read More
NicOx and Topigen terminate collaboration on anti-inflammatory drug TPI-1020
Read More
ReNeuron presents regulatory update on ReN-001 and ReN-009 stem cell therapies
Read More
Preclinical findings encourage clinical evaluation of mAb 1339 in multiple myeloma
Read More
Milk thistle extract silibinin shows potent activity in in patients with hepatitis C
Read More
Synthetic platelets show promise in rat model of major trauma
Read More
INX-189 displays potent inhibitory activity against HCV in vitro
Read More
Boehringer Ingelheim identifies novel MMP-13 inhibitors as potential arthritis therapeutics
Read More
Korea Research Institute of Chemical Technology discloses protein kinase inhibitors for cancer
Read More
Novel liver X receptor ligands disclosed by Organon Laboratories as atherosclerosis treatments
Read More
Array BioPharma describes novel kinase-inhibiting pyrrolopyridines as oncolytic agents
Read More
TaiGen Biotechnology claims novel HCV protease inhibitors
Read More
Facet Biotech enrolls first patient in phase II trial of elotuzumab in multiple myeloma
Read More
4SC treats first patient in a phase II trial of resminostat in Hodgkin's lymphoma
Read More
Cytokinetics reports data from phase I trial of skeletal muscle activator CK-2017357
Read More
Pluristem Therapeutics reports interim phase I results on PLX-PAD for critical limb ischemia
Read More
KemPharm presents encouraging results from phase I trial of KP-106 for ADHD
Read More